R&D Systems™ Recombinant Human HGF Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Human HGF Protein is derived from Sf 21 (baculovirus). The Recombinant Human HGF Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: P14210.2
• Formulation: Lyophilized from a 0.2 μm filtered solution in NaH 2 PO 4 and NaCl with BSA as a carrier protein.
• Gene ID (Entrez): 3082
• Molecular Weight (g/mol): Predicted MW: 53.7kDa ( alpha chain), 26kDa ( beta chain) Observed MW: 60-70kDa, non-reducing conditions 60kDa, and 33-34kDa, reducing conditions
• Name: HGF
• Quantity: 5 μg
• Source: Spodoptera frugiperda, Sf 21 (baculovirus)-derived human HGF protein Gln32-Ser728 (Asp384Asn, Asp416Asn, Leu622Ser, His645Arg, Val678Ile)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Structural Form: Disulfide-linked heterodimer
• Gene Alias: deafness, autosomal recessive 39, DFNB39, EC 3.4.21, EC 3.4.21.7, fibroblast-derived tumor cytotoxic factor, F-TCF, hepatocyte growth factor (hepapoietin A; scatter factor), Hepatopoeitin-A, Hepatopoietin A, HGFB, HPTA, HPTAhepatocyte growth factor, lung fibroblast-derived mitogen, Scatter factor, SF, SFhepatopoeitin-A
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Reconstitution: Reconstitute at 100μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin.
• Purity or Quality Grade: 95%, by SDS-PAGE under reducing conditions and visualized by silver stain.